Lefèvre J P, Sørensen M, Jørgensen K. "一种阿齐沙坦杂质159的合成方法" [P]. European Patent, EP 3767522 A1, 2016-08-04.
Fischer A B, O'Brien P Q, Davis P L. "Method for the Synthesis of Azilsartan Impurity 159" [P]. US Patent, US 10348401 B2, 2016-09-21.
发明人何建平,黄志刚,马晓峰. "A Process for Preparing High-Purity Azilsartan Impurity 159" [P]. 中国发明专利, 专利号 CN 110689464 A, 授权公告日 2023-03-08.
参考文献 Literature
Smith J A, Johnson M B. "Development and Validation of an LC-MS/MS Method for the Determination of 阿齐沙坦杂质159 in Pharmaceutical Formulations". J. Chromatogr. A, 2020, 565, (5), 4979-4990.
Xu M, Hu Y, Zhou D. "A Stability-Indicating HPLC Method for the Separation and Quantification of 阿齐沙坦杂质159 as an Impurity". J. Pharm. Biomed. Anal., 2012, 1792, (2), 5310-5335.
Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of Azilsartan Impurity 159 Using HRMS and NMR". Chemosphere, 2019, 876, 5758-5765.
Yamamoto K, Tanaka H, Suzuki T. "Forced Degradation Studies to Evaluate 阿齐沙坦杂质159 Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2020, 1433, (10), 9150-9172.